Nicole Graziano, - Physical Therapist in Wayne, NJ

Nicole Graziano, is a Physical Therapist based in Wayne, New Jersey. Nicole Graziano is licensed to practice in New Jersey (license number 40QA01809200) and her current practice location is 75 Darlington Dr, Wayne, New Jersey. She can be reached at her office (for appointments etc.) via phone at (973) 513-0443.

NPI number for Nicole Graziano is 1043790231 and her current mailing address is 75 Darlington Dr, Wayne, New Jersey. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1043790231.

Contact Information

Nicole Graziano,
75 Darlington Dr,
Wayne, NJ 07470-2840
(973) 513-0443
Not Available



Healthcare Provider's Profile

Full NameNicole Graziano
GenderFemale
SpecialityPhysical Therapist
Location75 Darlington Dr, Wayne, New Jersey
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1043790231
  • Provider Enumeration Date: 08/16/2018
  • Last Update Date: 08/16/2018

Medical Identifiers

Medical identifiers for Nicole Graziano such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1043790231NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225100000XPhysical Therapist 40QA01809200 (New Jersey)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Nicole Graziano is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Nicole Graziano,
75 Darlington Dr,
Wayne, NJ 07470-2840

Ph: (973) 513-0443
Nicole Graziano,
75 Darlington Dr,
Wayne, NJ 07470-2840

Ph: (973) 513-0443

News Archive

Oncolytics completes patient enrollment in phase II metastatic pancreatic cancer study

Oncolytics Biotech Inc. today announced completion of patient enrollment in a two-arm randomized phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer (OSU-10045).

Patients' risk of stroke increases following shingles, but antiviral drugs appear to offer protection

Patients' risk of stroke significantly increased following the first signs of shingles, but antiviral drugs appeared to offer some protection, according to a new study in Clinical Infectious Diseases, now available online.

ACT responds to FDA queries on Phase I/II study using ES cell derived retinal cells to treat SMD

Advanced Cell Technology, Inc. announced today that it has submitted documentation and a complete response to substantively address the issues raised by the US Food and Drug Administration (FDA) in connection with the Company's plans to initiate a Phase I/II multicenter study using embryonic stem (ES) cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD).

Janssen reports positive pivotal Phase 2 study data of siltuximab for Multicentric Castleman's Disease

Janssen Research & Development, LLC today announced positive results from a pivotal Phase 2 global registration study (MCD2001) suggesting siltuximab, an investigational compound, along with best supportive care, exhibited statistically significant efficacy and a tolerable safety profile compared with placebo and BSC in treating patients with the rare disorder Multicentric Castleman's Disease who are HIV-negative and human herpes virus 8-negative.

Every second counts when performing cardiac arrest resuscitation

A new study has found the number of people who survive after suffering a cardiac arrest outside a hospital drops significantly if the pause between stopping CPR and using a defibrillator to administer an electric shock is longer than 20 seconds.

Read more News

› Verified 9 days ago


Physical Therapist in Wayne, NJ

Performance Pt Llc
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 15 Corporate Dr Ste 6, Wayne, NJ 07470
Phone: 973-368-4907    Fax: 973-368-4909
Vertical Physical Therapy L.l.c.
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 81 Garside Ave, Wayne, NJ 07470
Phone: 973-919-5327    Fax: 201-812-7695
Jim Collins Pt
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 59 Joyce Lane, Wayne, NJ 07470
Phone: 917-699-8806    
Marianne A Kaleja, PT
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 224 Hamburg Tpke, Wayne, NJ 07470
Phone: 973-956-3360    
Janet Hansen, PT
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 820 Hamburg Tpke, Wayne, NJ 07470
Phone: 973-720-5831    Fax: 973-720-5841
Wayne Physical Therapy Llc
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 401 Hamburg Tpke Ste 102, Wayne, NJ 07470
Phone: 201-794-2121    Fax: 201-794-6003

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.